Literature DB >> 24890774

Imaging: diagnostic value of ultrasonography in Sjögren's syndrome.

Andreas V Goules1, Athanasios G Tzioufas1.   

Abstract

Salivary gland ultrasonography is a promising tool for the evaluation of Sjögren’s syndrome. Cumulative data suggest that ultrasonography is comparable with older imaging modalities such as sialography and scintigraphy. However, certain issues remain to be addressed before it can be integrated into current or future classification systems.

Entities:  

Mesh：

Year:  2014        PMID： 24890774     DOI： 10.1038/nrrheum.2014.86

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  9 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Ultrasonography of major salivary glands could be an alternative tool to sialoscintigraphy in the American-European classification criteria for primary Sjogren's syndrome.

Authors:  Vera Milic; Radmila Petrovic; Ivan Boricic; Goran Radunovic; Jelena Marinkovic-Eric; Predrag Jeremic; Nemanja Damjanov
Journal:  Rheumatology (Oxford)       Date:  2012-02-01       Impact factor: 7.580

3.  Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren's syndrome: a comparison with scintigraphy and biopsy.

Authors:  Vera D Milic; Radmila R Petrovic; Ivan V Boricic; Jelena Marinkovic-Eric; Goran L Radunovic; Predrag D Jeremic; Nada N Pejnovic; Nemanja S Damjanov
Journal:  J Rheumatol       Date:  2009-06-01       Impact factor: 4.666

4.  American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.

Authors:  S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

5.  Ultrasonography of salivary glands in primary Sjögren's syndrome: a comparison with contrast sialography and scintigraphy.

Authors:  F Salaffi; M Carotti; A Iagnocco; F Luccioli; R Ramonda; E Sabatini; M De Nicola; M Maggi; R Priori; G Valesini; R Gerli; L Punzi; G M Giuseppetti; U Salvolini; W Grassi
Journal:  Rheumatology (Oxford)       Date:  2008-06-19       Impact factor: 7.580

6.  Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria?

Authors:  Divi Cornec; Sandrine Jousse-Joulin; Jacques-Olivier Pers; Thierry Marhadour; Béatrice Cochener; Sylvie Boisramé-Gastrin; Emmanuel Nowak; Pierre Youinou; Alain Saraux; Valérie Devauchelle-Pensec
Journal:  Arthritis Rheum       Date:  2013-01

Review 7.  Classification criteria of Sjögren's syndrome.

Authors:  Andreas V Goules; Athanasios G Tzioufas; Haralampos M Moutsopoulos
Journal:  J Autoimmun       Date:  2014-01-21       Impact factor: 7.094

8.  Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren's syndrome.

Authors:  Divi Cornec; Sandrine Jousse-Joulin; Thierry Marhadour; Jacques-Olivier Pers; Sylvie Boisramé-Gastrin; Yves Renaudineau; Alain Saraux; Valérie Devauchelle-Pensec
Journal:  Rheumatology (Oxford)       Date:  2014-04-04       Impact factor: 7.580

9.  Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system.

Authors:  Elke Theander; Thomas Mandl
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-07       Impact factor: 4.794
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.